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Abstract 
AIM: The objective of the study was to evaluate protein expression in NIH 3T3 cells that are treated with virgin 
coconut oil (VCO) and hydrolysed of virgin coconut oil (HVCO) in vitro. 
METHODS: Coconut oil used in this study was virgin coconut oil (VCO) and VCO hydrolysed by Rhizomucor 
miehei (HVCO). NIH 3T3 cells (5x10
5
 cells/well) were seeded in nine wells and incubated for overnight, then 
divided into three groups. Each group consisted of three wells. Group one without treatment, group two added 
VCO, and group three added HVCO and then incubated for overnight. One well in each group was added MMP-9, 
PDGF-BB, and TGF-β1 and incubated one hour. Finally, expressions of MMP-9, PDGF-BB, and TGF-β1 were 
detected using immunocytochemistry method. 
RESULTS: The results of the study showed that VCO and HVCO increased protein expressions of MMP-9, 
PDGF-BB, and TGF-β1. Percentage of MMP-9 expressions treated by VCO increased from 2.89 ± 0.07 to 28.16 ± 
0.34, PDGF-BB from 28.11 ± 0.13 to 48.53 ± 0.49, and TGF-β1 from 4.19 ± 0.08 to 18.41 ± 0.54. Percentage of 
MMP-9 expressions treated by HVCO increased from 2.89 ± 0.07 to 55.40 ± 0.94, PDGF-BB from 28.11 ± 0.13 to 
61.65 ± 0.42, and TGF-β1 from 4.19 ± 0.08 to 36.35 ± 0.67. 
CONCLUSION: VCO and HVCO increase the expression of MMP-9, PDGF-BB, dan TGF-β1 in NIH3T3 cells and 
therefore, coconut oil active in the wound healing process. HVCO is more than active than VCO. 
 
 
 
 
 
 
Introduction 
 
Wound healing is a complicated and dynamic 
process including proliferation, differentiation, 
migration of keratocytes and their elaboration of the 
new extracellular matrix (ECM) [1]. Wound healing 
consists of four phases, namely hemostasis, 
inflammation, proliferation, and remodelling [2]. 
Hemostasis phase is the beginning of the wound 
healing process by involving platelets [3]. During the 
inflammatory phase, fibroblasts function as cytokine 
secretion, and growth factors to activate the body's 
defence system [4]. During the proliferation, wound 
healing is a complicated and dynamic process 
including proliferation, differentiation, migration of 
keratocytes and their elaboration of the new 
extracellular matrix (ECM) [1]. In the hemostasis, the 
phase is the beginning of the wound healing process 
by involving platelets [3]. During the inflammatory 
phase, fibroblasts function as cytokine secretions, and 
growth factors to activate the body's defence system 
[4]. During the proliferation and remodelling phases, 
fibroblasts are important for granulating and 
reorganising tissues of the extracellular matrix. So, a 
healing wound shows an elaborate series of 
interactions cytokines, growth factors, ECM 
constituent, receptors, proteases, cells, and dissolved 
mediators [5]. Matrix metalloproteinases (MMPs) take 
part in many physiological and pathological 
processes, such as morphogenesis, wound healing, 
tissue repair, and remodelling [6] and increasing cell 
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growth, migration, invasion, metastasis, and 
angiogenesis [5]. Lately, substantial interest has 
concentrated on matrix metalloproteinase 9 (MMP-9), 
a significant MMP family member. Transforming 
growth factor-beta 1 (TGF-β1), platelet-derived growth 
factor-BB (PDGF-BB), and fibroblast growth factor 
(FGF) are examples of GFs involved in cell 
proliferation and migration [1], [6]. 
Coconut oil is the most saturated oil compose 
of medium-chain fatty acids, including capric (7%), 
lauric (49%), myristic (18%), palmitic (9%), stearic 
(2%), and small percentages of unsaturated fatty 
acids that including oleic (6%) and linoleic acids (2%) 
[7]. VCO isolated from mature coconut fruit and 
processed at low temperature without chemical 
refining, bleaching or deodorising, and which does not 
lead to the conversion of the nature of the oil [8]. VCO 
contains more biological active constituent such as 
tocopherols, sterols, polyphenols, and squalene [9]. 
VCO contains lauric acid, which has antimicrobial, 
anti-viral, anti-fungal and antibacterial properties [8]. 
Partial hydrolysis of VCO (HVCO) using lipase from 
Rhizomucor miehei which is active on sn-1, 3 
positions in triglyceride molecule resulted in free fatty 
acids and 2-monoglyceride mainly a mixture of lauric 
acids and more active antibacterial monolaurin [10], 
[11], [12]. VCO and HVCO had been tested by in vivo 
method and found to be active in wound healing and 
more active compared to the bioplacenton as a 
standard medicine for burn wound healing [13]. 
This research aims to determine the role of 
VCO and HVCO in wound healing by measuring the 
expression of MMP-9, PDGF-BB, and TGF-β1 in NIH 
3T3 in vitro. 
 
 
Material and Methods 
 
Materials 
Virgin coconut oil (VCO) (Palem Mustika®, 
Indonesia), NIH 3T3 fibroblasts were purchased from 
Parasitology Laboratory, Faculty of Medicine, Gadjah 
Mada University. The cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% Fetal bovine serum and kept 
at 37°C with a CO2 supply of 5%. Lipase from R. 
miehei 20.000 U/g (Sigma) and reagents used were 
buffer Tris-HCl, sodium hydroxide, concentrated 
hydrochloric acid, distilled water, n-hexane, sodium 
sulfate anhydrous, potassium hydrogen phthalate, 
phenolphthalein, primer antibody (MMP-9, PDGF-BB, 
TGF-β1) and ethanol. Reagents that used to 
immunocytochemical assay. All chemicals and 
reagents used in this work were of analytical grade. 
 
 
Enzymatic hydrolysis of VCO 
Thirty (30) g of oil was transferred into 250 ml 
Erlenmeyer flask, and then, 30 ml distilled water, 12.5 
ml 0.063 M CaCl2, 25 ml buffer Tris-HCl 1 M pH 8, 
and 3 ml lipase R. miehei were added. The mixture 
was stirred at 200 rpm for 10 min of every 1 h 
incubation time. The mixture was incubated at 50°C at 
10 h. At the end of the mixture incubation time, the 
mixture was transferred into the separating funnel, 
and then, extracted with 50 ml n-hexane. The mixture 
was allowed to stand for some time until two layers 
were separated. The upper layer (n-hexane fraction) 
was separated as the first extract, while the bottom 
layer (water fraction) was extracted again as above 
and separated as the second extract. The first and the 
second extracts were mixed, and then, 250 g sodium 
sulfate anhydrous was added to absorb the water 
residue. The combined extract was allowed to stand 
for 15 min, filtered, and the n-hexane was evaporated 
using the water bath. The hydrolysed VCO (HVCO) 
was then used in the experiment [10], [11], [12]. 
 
Immunocytochemical Assay 
NIH 3T3 cells (5 x 10
5
 cells/well) were seeded 
into 9 wells with a coverslip in 24-well plate and 
incubated for 24 h. Wells were grouped, they 
consisted of control groups (without VCO or HVCO), 
VCO groups, and HVCO groups. After that, the cells 
were treated with 500 µL VCO (62.5 µg/mL) in 
medium and 500 µL HVCO (62.5 µg/mL) in medium 
and then incubated for 24 h. The medium was taken, 
washed with PBS 2 times. Then cells in coverslips 
fixed with cold methanol and washed PBS 2 times, 
then washed 2 times with distilled water. Coverslips 
moved in a slide then added 300 µL H2O2 (1: 9 in 
distilled water), then incubated for 10 minutes, 
discarded and washed with PBS 2 times. Then added 
100 µL Blocking (Background Snipper), incubate for 
15 minutes at room temperature, discarded and 
added 50 µL of primary antibody (MMP-9, PDGF-BB, 
TGF-β1) incubation for 60 minutes. After discarded 
washed again with PBS 2 times, then added 100 µL of 
secondary antibody (Trekkie Link) incubated for 20 
minutes on room temperature.  
The secondary antibody was removed, 
washed with PBS 2 times and added Avidin HRP 
Tracks, incubated for 10 minutes at temperature 
room, discarded and washed with PBS 2 time. 
Continued with the addition of 100 µL of DAB, 
incubated for 5 minutes, removed, and washed with 
distilled water. After being discarded and cleaned with 
tissue, added with 300 µL Mayer-hematoxylin and 
incubated 5 minutes. Then washed with distilled water 
until clean. Slide (preparation) dipped in ethanol, then 
dipped in xylol. After drying it was covered with a 
glass cover and added enter. Protein expression 
observed using a microscope. If protein gave 
brown/dark colour in the cytoplasm of all cells was 
positive. If protein gave blue/purple was negative Data 
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analysis with Image Raster software was carried out 
to calculate the expression of MMP-9, PDGF BB, and 
TGF-β1 protein. The results of the analysis are 
through the image quantification of the average 5 
(five) field of view [14]. 
 
Statistics  
 One-way analysis of ANOVA followed by 
Tukey’s post hoc test was used to analyse data (p < 
0.05). 
 
 
Results  
 
Observation of protein expression of MMP-9, 
PDGF-BB, and TGF-β1 in NIH 3T3 cells was done by 
comparing the protein expression of MMP-9, PDGF-
BB, and TGF-β1 without treatment (as a control) with 
VCO and HVCO treatment. The data were obtained in 
the form of percentage expressions of MMP-9, PDGF 
BB, and TGF-β1 in 5 fields of view (Figure 1, Table 1, 
and Figure 2).  
 
Figure 1: Effect of VCO 62.5 µg/mL and HVCO 62.5 µg/mL 
treatment on NIH 3T3 cells. Cells were observed with a microscope 
(40 x magnifications) 
 
 As can be seen, VCO and HVCO increased 
protein expression tested. Percentage of MMP-9 
expressions were increased from 2.89 ± 0.07 (control) 
to 28.16 ± 0.34 (VCO), and 55.40 ± 0.94 (HVCO).  
Table 1: Effect of VCO and HVCO on NIH 3T3 cells towards 
MMP-9, PDGF-BB, and TGF-β1 
Group (n = 3) 
Protein Expression (%) 
(Mean ± SEM) 
MMP-9 PDGF-BB TGF-β1 
Control 2.89 ± 0.07 28.11 ± 0.13 4.19±0.08 
VCO 28.16 ± 0.34* 48.53 ± 0.49* 18.41±0.54* 
HVCO 55.40 ± 0.94* 61.65 ± 0.42* 36.35±0.67* 
Values are mean ± SEM; Statistics-one-way ANOVA followed by Tukey’s post hoc test; *p 
< 0.05 significantly difference; n = number of observers in each group; SEM: Standard 
error of the mean. 
 
 Percentage of PDGF-BB expressions were 
increased from 28.11 ± 0.13 (control), to 48.53 ± 0.49 
(VCO) and 61.65 ± 0.42 (HVCO). Percentage TGF-β1 
expressions were increased from 4.19 ± 0.08 (control) 
to 18.41 ± 0.54 (VCO) and 36.35 ± 0.67 (HVCO). 
 
 
 
Figure 2: The effect of treatment with VCO and HVCO on the 
expression of MMP-9, PDGF-BB, and TGF-β1(*p > 0.05 = different 
significant compared control) 
 
 
Discussion 
 
According to on the above Figure 1, Table 1, 
and Figure 2 can be seen that VCO and HVCO can 
increase the expression of the protein of MMP-9, 
PDGF-BB, and TGF-β1 increased proliferation, 
migration, angiogenesis, which play a role in the 
wound healing process. Then VCO and HVCO can be 
active in the wound healing process. According to 
Silalahi and Surbakti (2015) reported that HVCO (12 
days) found to be more effective than VCO (17 days) 
in the wound healing process, compared with 
bioplacenton (18 days) as standard medication [13]. 
The individual effect of TGFβ1, PDGF- BB, and bFGF 
on cell proliferation and differentiation during the 
repair process were studied at different time points 
until wound closure by Munoza, et al., 2017 [1]. TGF-
β1 excited proliferation in the wound site and the 
surrounding area, persuade myofibroblast 
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differentiation and inhibited cellular migration. PDGF-
BB persuade rapid wound closure proliferation, high 
motility. Each of the GFs induced increased in 
responses promoting stromal repair differently. Matrix 
metalloproteinases (MMPs) belong to the family of 
zinc-dependent endopeptidases, whose primary 
function is to degrade the extracellular matrix (ECM) 
[5]. MMPs participate in many physiological and 
pathological processes, such as morphogenesis, 
wound healing, tissue repair, and remodelling [5]. 
MMP-9 is an important MMP family [5]. MMP-9, a type 
IV collagenase, may show a major role during cell 
growth, inflammation, and angiogenesis [15]. VCO 
contains lauric acid, which has antimicrobial, anti-viral, 
anti-fungal and antibacterial properties [8]. VCO and 
HVCO contain bioactive components which play a role 
in wound healing [15]. A few studies have reported the 
benefits of lauric acid as an antimicrobial and anti-
inflammatory agent that can help to overcome skin 
problems [8]. Fatty acids are important components of 
cell membranes, high promotes the inflammatory 
process on wound healing [15]. So that, VCO and 
HVCO by increasing expression MMP-9, PDGF-BB, 
and TGF-β1may play an important role in the wound 
healing process. 
In conclusion, treatment with VCO and HVCO 
on NIH 3T3 cells increase MMP-9, PDGF-BB, and 
TGF-β1expressions and hence play a role in the 
wound healing process. 
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